Subacute cutaneous lupus erythematosus (SCLE) is a rare eruption related to several pharmacological and chemotherapy agents. We present a 63-year-old female with recurrent epithelial ovarian cancer who developed SCLE after administration of gemcitabine. Following discontinuation of gemcitabine and after oral steroid treatment, all skin lesions disappeared. In view of the extensive use of gemcitabine in recurrent ovarian cancer, it is important to be aware of the possibility of SCLE occurrence in these patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000443762 | DOI Listing |
Publication Analysis
Top Keywords
subacute cutaneous
8
cutaneous lupus
8
lupus erythematosus
8
ovarian cancer
8
gemcitabine-induced subacute
4
erythematosus case
4
case report
4
report subacute
4
erythematosus scle
4
scle rare
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!